The new collaboration between GSK and the Univeristy of Oxford aims to explore cancer prevention through vaccination.

Pharmacies play a key role in improving drug development and patient care, offering insights, clinical trial support and ...

The FDA will review a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

A new partnership between the University of Oxford and GSK aims to develop vaccines against cancer before develop ...

Oxford University and pharmaceutical giant GSK are creating a new cancer vaccine to prevent the disease from developing. The partnership intends to create a vaccine or vaccines which target cells at ...

Scientists at Oxford University, which pioneered Covid-19 vaccines, turn attention to ‘detecting the undetectable’ and ...

GSK plc (LSE/NYSE: GSK) today announced that the European Medicines Agency (EMA) has accepted for review the regulatory application of a prefilled syringe presentation of Shingrix (GSK’s Recombinant ...

The pharma group has pledged up to £50 million ($62.5 million) in funding over three years for the initiative, which builds ...

Oxford University is hoping to create a vaccine to stop the disease 20 years before it develops, as part of a joint project ...

A new cancer vaccine that ‘stops disease before you get it’ is being created by pharmaceutical giant GSK and the University ...

Scientists at Oxford University and drugmaker GSK to ‘detect the undetectable’ and identify changes in cells that start up to ...